Literature DB >> 19937689

Diagnostic power of fibroscan in predicting liver fibrosis in nonalcoholic fatty liver disease.

Anna Alisi, Massimo Pinzani, Valerio Nobili.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19937689     DOI： 10.1002/hep.23345

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  9 in total

1.  Acoustic radiation force impulse elastography of the liver: can fat deposition in the liver affect the measurement of liver stiffness?

Authors:  Utaroh Motosugi; Tomoaki Ichikawa; Yoshibumi Niitsuma; Tsutomu Araki
Journal:  Jpn J Radiol       Date:  2011-09-29       Impact factor: 2.374

2.  Quantitative analysis of real-time tissue elastography for evaluation of liver fibrosis.

Authors:  Ying Shi; Xing-Hua Wang; Huan-Hu Zhang; Hai-Qing Zhang; Ji-Zheng Tu; Kun Wei; Juan Li; Xiao-Li Liu
Journal:  Int J Clin Exp Med       Date:  2014-04-15

3.  Assessment of liver stiffness measurement: novel intraoperative blood loss predictor?

Authors:  Min-Soo Kim; Jeong-Rim Lee
Journal:  World J Surg       Date:  2013-01       Impact factor: 3.352

Review 4.  Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis.

Authors:  Jiulian Gu; Shousheng Liu; Shuixian Du; Qing Zhang; Jianhan Xiao; Quanjiang Dong; Yongning Xin
Journal:  Eur Radiol       Date:  2019-03-21       Impact factor: 5.315

5.  Initial evaluation of hepatic T1 relaxation time as an imaging marker of liver disease associated with autosomal recessive polycystic kidney disease (ARPKD).

Authors:  Ying Gao; Bernadette O Erokwu; David A DeSantis; Colleen M Croniger; Rebecca M Schur; Lan Lu; Jose Mariappuram; Katherine M Dell; Chris A Flask
Journal:  NMR Biomed       Date:  2015-11-26       Impact factor: 4.044

6.  Diagnostic accuracy assessment of molecular prediction model for the risk of NAFLD based on MRI-PDFF diagnosed Chinese Han population.

Authors:  Qing Zhang; Yueli Zhu; Wanjiang Yu; Zhipeng Xu; Zhenzhen Zhao; Shousheng Liu; Yongning Xin; Kuirong Lv
Journal:  BMC Gastroenterol       Date:  2021-02-25       Impact factor: 3.067

7.  A cross-sectional study assessing the relationship between non-alcoholic fatty liver disease and periodontal disease.

Authors:  Satsuki Sato; Yohei Kamata; Takaomi Kessoku; Tomoko Shimizu; Takashi Kobayashi; Takeo Kurihashi; Shogo Takashiba; Kazu Hatanaka; Nobushiro Hamada; Toshiro Kodama; Takuma Higurashi; Masataka Taguri; Masato Yoneda; Haruki Usuda; Koichiro Wada; Atsushi Nakajima; Toshiya Morozumi; Masato Minabe
Journal:  Sci Rep       Date:  2022-08-10       Impact factor: 4.996

8.  Cytokeratin 18, alanine aminotransferase, platelets and triglycerides predict the presence of nonalcoholic steatohepatitis.

Authors:  Wei Cao; Caiyan Zhao; Chuan Shen; Yadong Wang
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

9.  Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial.

Authors:  Yohei Kamata; Takaomi Kessoku; Tomoko Shimizu; Takashi Kobayashi; Takeo Kurihashi; Satsuki Sato; Syotaro Kuraji; Norio Aoyama; Tomoyuki Iwasaki; Shogo Takashiba; Nobushiro Hamada; Toshiro Kodama; Toshiyuki Tamura; Satoshi Ino; Takuma Higurashi; Masataka Taguri; Takeharu Yamanaka; Masato Yoneda; Haruki Usuda; Koichiro Wada; Atsushi Nakajima; Masato Minabe
Journal:  Trials       Date:  2020-03-23       Impact factor: 2.279
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.